QuantumSi is trading at $0.82 (5.1% down) amid a broader risk-off tone hitting the biotech sector and growth stocks, despite a lack of fresh company-specific news or filings.
- The decline aligns with a wider sell-off in the Nasdaq and the SPDR S&P Biotech ETF (XBI), which is currently trading 2% lower.
- Investors appear to be trimming exposure to volatile, high-beta names like QuantumSi that have been pressured by weak fundamentals and prior dilution concerns.